amifostine anhydrous has been researched along with Embryopathies in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kajbafzadeh, AM | 1 |
| Sabetkish, N | 1 |
| Sabetkish, S | 1 |
| Javan-Farazmand, N | 1 |
| Harsini, S | 1 |
| Tavangar, SM | 1 |
1 other study available for amifostine anhydrous and Embryopathies
| Article | Year |
|---|---|
The ameliorative effect of various antioxidants on Adriamycin-induced fetal renal abnormalities.
Topics: Amifostine; Animals; Antibiotics, Antineoplastic; Antioxidants; Deferoxamine; Disease Models, Animal | 2013 |